ContextVision AB is a Sweden-based medical technology software company specialized in image analysis and artificial intelligence. The Company is engaged in the image enhancement market and is a partner to the manufacturers of ultrasound, X-ray and Magnetic Resonance Imaging (MRI) equipment around the world. The Company develops software products, based on proprietary technology and artificial intelligence for image-based applications. ContextVisionâ€™s cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The Company operates through two separate segments: the Business Unit Medical Imaging and the Business Unit Digital Pathology. ContextVision has two subsidiaries: Inify Laboratories AB og ContextVision Inc.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

11-05 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
02/11/26	NOK 4.370	+4.05%	13,906
30/10/26	NOK 4.200	-6.67%	173,549
29/10/26	NOK 4.500	-0.66%	116,689
28/10/26	NOK 4.530	-2.58%	105,026
27/10/26	NOK 4.650	+4.26%	20,198

Real-time Oslo Bors

More quotes

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - ContextVision AB

Company calendar

Market Closed - Oslo Bors 19:45:00 02/11/2026 +04			5-day change	1st Jan Change
4.370 ^NOK	+4.05%		-2.67%	+3.07%

10-22	ContextVision Forms Partnership for Validation of Quantitative Imaging Technology	MT
10-22	Contextvision AB Signs Partnership Agreement with Linköping University, Region Östergötland, and the Center for Medical Image Science and Visualization for the Clinical Translation of Its Quantitative Imaging Portfolio	CI

Market Cap	348M 37.49M 33.47M 30.72M 27.94M 52.38M 3.55B 53.43M 367M 148M 1.87B 141M 138M 5.92B	P/E 2024	16.7x	P/E 2025	375x
Enterprise Value	291M 31.32M 27.96M 25.66M 23.34M 43.76M 2.97B 44.63M 306M 124M 1.57B 118M 115M 4.94B	EV / Sales 2024	2.67x	EV / Sales 2025	2.13x
Free-Float	33.31%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Oslo Bors	CONTX	Real-time
CBOE	COVo	Real-time
Nasdaq Stockholm	CONTXO	Delayed
CBOE	0L8Z	Real-time

10-22	ContextVision Forms Partnership for Validation of Quantitative Imaging Technology	MT
10-22	Contextvision AB Signs Partnership Agreement with Linköping University, Region Östergötland, and the Center for Medical Image Science and Visualization for the Clinical Translation of Its Quantitative Imaging Portfolio	CI
09-18	ContextVision AB (OB:CONTX) commences an Equity Buyback Plan for 2,000,000 shares for NOK 12 million, under the authorization approved on May 12, 2026.	CI
09-10	ContextVision to Launch Up to NOK12 Million Share Repurchase Program	MT
09-01	ContextVision AB, H1 2026 Earnings Call, Aug 27, 2026
08-27	ContextVision AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-14	ContextVision AB, Q1 2026 Pre Recorded Earnings Call, May 08, 2026
05-12	ContextVision AB 's Equity Buyback announced on September 15, 2025, has expired with	CI
05-08	Tranche Update on ContextVision AB (OB:CONTX)'s Equity Buyback Plan announced on September 15, 2025.	CI
05-08	ContextVision AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-08	ContextVision AB Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-07	ContextVision Terminates Market-making Deal with Norne Securities	MT
03-26	ContextVision and BeamWorks Partner to Advance Ai-Powered Quantitative Ultrasound Imaging Solutions	CI

ContextVision AB Stock

Stocks

CONTX

SE0014731154

Advanced Medical Equipment & Technology

Valuation: ContextVision AB

Chart: ContextVision AB

Latest news: ContextVision AB

Last Transcript: ContextVision AB

Analysts' recommendations: ContextVision AB

Press Releases: ContextVision AB

News in other languages: ContextVision AB

Quotes and Performance

Price Extremes

Managers and Directors: ContextVision AB

Latest insider transactions

Medical Software & Technology Services

Financials

Company Profile

Quotes

Quarterly revenue - Rate of surprise

07/05/25	Norne Securities downgrades Contextvision to hold (buy), target price NOK 5.50 - BN	FW
24/04/25	Norne Securities upgrades Contextvision to Buy (Hold), target price NOK 7 - BN	FW
25/02/25	Norne Securities downgrades Contextvision to Hold (Buy), target price NOK 7 - BN	FW
30/08/24	Today's stock recommendations at a glance	FW
30/08/24	Norne Securities lowers target price for Contextvision to NOK 6.50 (6.80), reiterates Hold - BN	FW

10-29	ContextVision AB: Transactions made under the buy-back programme	PU
10-08	ContextVision AB: Transactions made under the buy-back programme	AQ
09-29	ContextVision AB: Transactions made under the buy-back programme	AQ
09-18	ContextVision AB: Transactions made under the buy-back programme	AQ
09-09	Initiation of share buyback program	AQ

1 day	+4.05%
1 week	-2.67%
Current month	+4.05%
1 month	-17.55%
3 months	+27.03%
6 months	+21.73%
Current year	+3.07%

1 week	4.16	4.65
1 month	4.14	5.42
Current year	2.7	5.78
1 year	2.7	5.78
3 years	2.7	9.2
5 years	2.7	24.4
10 years	2.7	30.9

Manager	Title	Age	Since
Gerald Pötzsch CEO	Chief Executive Officer	54	01/08/2022
Richard Hallström DFI	Director of Finance/CFO	-	28/08/2023
Marco Marien Voormolen CTO	Chief Tech/Sci/R&D Officer	-	02/03/2026

Director	Title	Age	Since
Martin Hedlund BRD	Director/Board Member	74	01/01/1997
Sven Günther-Hanssen BRD	Director/Board Member	72	01/01/2011
Knut Martin Henschen Ingvar BRD	Director/Board Member	71	01/01/2020

Date	Insider	Type	Main position	Quantity	% Market Cap.
20/02/23	Gerald Pötzsch	Buy	Chief Executive Officer	10,000	0.0129%
02/11/22	Gerald Pötzsch	Buy	Chief Executive Officer	10	0.0000%
02/11/22	Gerald Pötzsch	Buy	Chief Executive Officer	1,000	0.0013%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CONTEXTVISION AB	+4.05%	-2.67%	+0.92%	-38.45%	34.02M
THERMO FISHER SCIENTIFIC, INC.	-2.06%	-0.33%	+20.85%	+52.52%	258B
DANAHER CORPORATION	-1.83%	-2.15%	+6.50%	+18.13%	163B
INTUITIVE SURGICAL, INC.	+1.12%	-3.27%	-19.72%	+57.21%	150B
BOSTON SCIENTIFIC CORPORATION	+5.57%	-2.76%	-55.05%	-15.61%	60.84B
SIEMENS HEALTHINEERS AG	+1.19%	+2.62%	-11.10%	-8.42%	53.31B
EDWARDS LIFESCIENCES CORPORATION	+1.36%	+2.98%	+12.27%	+42.32%	53.03B
VEEVA SYSTEMS INC.	-1.90%	-3.51%	+4.88%	+61.66%	50.67B
AGILENT TECHNOLOGIES, INC.	-1.65%	-2.26%	+18.87%	+64.63%	49.3B
WATERS CORPORATION	-2.85%	-1.41%	+30.08%	+83.18%	45.46B
Average	+0.01%	-0.92%	+0.85%	+31.72%	88.4B
Weighted average by Cap.	-1.04%	+0.15%	+3.11%	+40.76%

	2024	2025
Net sales	131M 14.09M 12.58M 11.54M 10.5M 19.68M 1.33B 20.08M 138M 55.57M 704M 52.87M 51.74M 2.22B	110M 11.89M 10.61M 9.74M 8.86M 16.61M 1.13B 16.94M 116M 46.9M 594M 44.62M 43.67M 1.88B
Net income	24.68M 2.66M 2.38M 2.18M 1.98M 3.72M 252M 3.79M 26.04M 10.49M 133M 9.99M 9.77M 420M	787K 84.84K 75.75K 69.51K 63.23K 119K 8.03M 121K 830K 335K 4.24M 318K 312K 13.39M
Net Debt	-63.9M -6.89M -6.15M -5.64M -5.13M -9.63M -652M -9.82M -67.41M -27.17M -344M -25.85M -25.3M -1.09B	-57.24M -6.17M -5.51M -5.06M -4.6M -8.62M -584M -8.79M -60.38M -24.34M -308M -23.16M -22.67M -974M